Hypophosphatemia in pregnancy: A case report
Main Article Content
Keywords
Rickets, Hypophosphatemia, Fibroblast Growth Factor Gene 23, Pregnancy
Abstract
Autosomal hypophosphatemic rickets though a rare genetic disorder can lead to significant discomfort to the patient resulting in clinical deterioration and a poor quality of life. We describe a case of a 33-year-old woman G2P1001 at 6 weeks of gestation with complaints of myalgia and bony pains. Keeping her history of bony pains and fractures in mind, she was further evaluated. On evaluation, she was found to have low levels of phosphates 0.99 mg/dl (2.40-4.40) and high levels of fibroblast growth factor 23 (FGF 23) 231.70pg/ml (23.20-95.40). These biochemical parameters were suggestive of hypophosphatemic rickets and further on gene sequencing she was found to have autosomal dominant hypophosphatemic rickets (HR). During her follow-up visits, her checkup and antenatal investigations were normal. Pregnancy acts as a stressor and patients with asymptomatic ADHR may present during pregnancy for the first time with the symptoms of HR. So, a high index of suspicion is required for patients reporting musculoskeletal pains in pregnancy. Early diagnosis can help the mother have a better pregnancy experience. Phosphate and vitamin D supplementation during pregnancy can help these women reduce musculoskeletal pain symptoms. Unfortunately, this patient had a spontaneous abortion in the second trimester. The overall prevalence of ADHR is less than 1 per 1,00,000 live births. Data in pregnancy with ADHR is also minimal due to the condition's rarity. Hence, more and more studies are required in pregnancy with this disease to come to any conclusion and to find any association of ADHR with pregnancy outcomes. Genetic counselling and the need for testing in newborns if symptomatic is also an essential factor to remember when coming across such antenatal patients.
References
2. Carpenter TO, Shaw NJ, Portale AA, Ward LM, Abrams SA, Pettifor J. Rickets. Nat. Rev. Dis. Prim. 2017; 3:17101. doi: 10.1038/nrdp.2017.101.
3. Linglart A, Duplan MB, Briot K, Chaussain C, Esterle L, Guillaume-Czitrom S, et a l. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect 2014;3: R13–R30. doi: 10.1530/EC-13-0103.
4. Liu C, Zhao Z, Wang O, Li M, Xing X, Hsieh E, Fukumoto S, Jiang Y, Xia W. Earlier Onset in Autosomal Dominant Hypophosphatemic Rickets of R179 than R176 Mutations in Fibroblast Growth Factor 23: Report of 20 Chinese Cases and Review of the Literature. Calcif Tissue Int. 2019;105:476–486. doi: 10.1007/s00223-019-00597-y.
5. Kapelari K, Köhle J, Kotzot D, Hoegler W. Iron Supplementation Associated with Loss of Phenotype in Autosomal Dominant Hypophosphatemic Rickets. J. Clin. Endocrinol. Metab. 2015;100:3388–3392. doi 10.1210/jc.2015-2391.
6. Econs MJ, McEnery PT. Autosomal Dominant Hypophosphatemic Rickets/Osteomalacia: Clinical Characterization of a Novel Renal Phosphate-Wasting Disorder. J. Clin. Endocrinol. Metab. 1997; 82:674–681. doi: 10.1210/jcem.82.2.3765.
7. Kruse K, Woelfel D, Strom TM. Loss of Renal Phosphate Wasting in a Child with Autosomal Dominant Hypophosphatemic Rickets Caused by a FGF23 Mutation. Horm. Res. Paediatr. 2001; 55:305–308. doi: 10.1159/000050018.
8. Negri AL, Negrotti T, Alonso G, Pasqualini T. Distintasformas de presentacionclinicade unraquitismohipofosfatemicoautosomico dominante pormutaciondel factor de crecimientofibroblastico 23 en unafamilia. Medicina (B Aires) 2004; 64:103–106.
9. Gribaa M, Younes M, Bouyacoub Y, Korbaa W, Ben Charfeddine I, Touzi M, et al. An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J. Bone Miner. Metab. 2009; 28:111–115.doi: 10.1007/s00774-009-0111-5.
10. Sandal S, Arora V, Verma LC. Hypophosphatemic Rickets with R179W Mutation in FGFR23 Gene-A Rare but Treatable Cause of Refractory Rickets. Indian J. Pediatr. 2021; 88:61–63. doi: 10.1007/s12098-020-03335-7.
11. Farrow EG, Yu X, Summers LJ, Davis SI, Fleet JC, Allen MR, et al. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(46): E1146–E1155. doi: 10.1073/pnas.1110905108.
12. Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, Econs MJ. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. The Journal of Clinical Endocrinology & Metabolism. 2011;96(11):3541–3549. doi: 10.1210/jc.2011-1239.
13. Dobrowolska-Redo A, Teliga-Czajkowska J, Sotowska A, Romejko-Wolniewicz K, Zaręba-Szczudlik J, Malinowska-Polubiec A, et al. Pregnancy in a patient with X-linked hypophosphatemic rickets – management and outcome. Clin Exp Obstet Gynecol 2018; XLV(5):794-796. DOI: 10.12891/ceog4385.2018
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.